| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Actinogen Medical Limited (PINK: ATGGF)
ATGGF Technical Analysis
5
| As on 1st Jan 2026 ATGGF STOCK Price closed @ 0.04 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 0.00 & Strong Buy for SHORT-TERM with Stoploss of 0.00 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ATGGFSTOCK Price
| Open | 0.02 | Change | Price | % |
| High | 0.04 | 1 Day | 0.02 | 100.00 |
| Low | 0.02 | 1 Week | 0.03 | 300.00 |
| Close | 0.04 | 1 Month | 0.03 | 300.00 |
| Volume | 12500 | 1 Year | 0.03 | 300.00 |
| 52 Week High 0.04 | 52 Week Low 0.01 | ||||
PINK USA Most Active Stocks
| ECOX | 0.00 | % |
| GTVH | 0.00 | % |
| CIVX | 0.00 | % |
| LTNC | 0.00 | % |
| IGEX | 0.00 | % |
| AURI | 0.00 | % |
| VNUE | 0.00 | % |
| EARI | 0.00 | % |
| TRSI | 0.00 | % |
| HMBL | 0.00 | % |
PINK USA Top Gainers Stocks
PINK USA Top Losers Stocks
| ATGGF Daily Charts |
ATGGF Intraday Charts |
Whats New @ Bazaartrend |
ATGGF Free Analysis |
|
|
ATGGF Important Levels Intraday
| RESISTANCE | 0.08 |
| RESISTANCE | 0.07 |
| RESISTANCE | 0.06 |
| RESISTANCE | 0.05 |
| SUPPORT | 0.03 |
| SUPPORT | 0.02 |
| SUPPORT | 0.01 |
| SUPPORT | 0.00 |
ATGGF Forecast March 2026
| 4th UP Forecast | 0.1 |
| 3rd UP Forecast | 0.08 |
| 2nd UP Forecast | 0.07 |
| 1st UP Forecast | 0.06 |
| 1st DOWN Forecast | 0.02 |
| 2nd DOWN Forecast | 0.01 |
| 3rd DOWN Forecast | 0 |
| 4th DOWN Forecast | -0.02 |
ATGGF Weekly Forecast
| 4th UP Forecast | 0.10 |
| 3rd UP Forecast | 0.08 |
| 2nd UP Forecast | 0.07 |
| 1st UP Forecast | 0.06 |
| 1st DOWN Forecast | 0.02 |
| 2nd DOWN Forecast | 0.01 |
| 3rd DOWN Forecast | 0.00 |
| 4th DOWN Forecast | -0.02 |
ATGGF Forecast2026
| 4th UP Forecast | 0.1 |
| 3rd UP Forecast | 0.08 |
| 2nd UP Forecast | 0.07 |
| 1st UP Forecast | 0.06 |
| 1st DOWN Forecast | 0.02 |
| 2nd DOWN Forecast | 0.01 |
| 3rd DOWN Forecast | 0 |
| 4th DOWN Forecast | -0.02 |
Actinogen Medical Limited ( PINK USA Symbol : ATGGF )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ATGGF Business Profile
Actinogen Medical Limited, a biotechnology company, develops therapies for cognitive impairment associated with chronic neurological diseases in Australia. The company is developing Xanamem, a therapy for Alzheimer's disease, and cognitive impairment associated with schizophrenia, diabetes, and other disorders; and XanADu, which has completed Phase II clinical trials is a double-blind, randomized, and placebo-controlled study to assess the safety, tolerability, and efficacy of Xanamem in subjects with mild Alzheimer's disease. It is also developing XanaHES, a single blinded, central reader blinded, placebo-controlled, and dose escalation study of Xanamem to assess safety and tolerability in healthy elderly subjects. The company was formerly known as Actinogen Limited and changed its name to Actinogen Medical Limited in November 2015. Actinogen Medical Limited was incorporated in 1999 and is headquartered in Sydney, Australia. Address: 109 Pitt Street, Sydney, NSW, Australia, 2000
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service